Aynur Kirbas
Overview
Explore the profile of Aynur Kirbas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cumhur Cure M, Cure E, Kalkan Y, Kirbas A, Tumkaya L, Yilmaz A, et al.
Balkan Med J
. 2016 Oct;
33(5):504-511.
PMID: 27761277
Background: Cisplatin (Cis) is one of the most commonly used antineoplastic drugs. It is used as chemotherapy for many solid organ malignancies such as brain, neck, male and female urogenital,...
2.
Kurt A, Turut H, Acipayam A, Kirbas A, Yuce S, Cumhur Cure M, et al.
BMJ Open
. 2016 Oct;
6(10):e011797.
PMID: 27733410
Objective: Multiple rib fractures (RFs) and pulmonary contusions (PCs), with resulting systemic lung inflammation, are the most common injuries caused by blunt chest trauma (BCT) in motor vehicle accidents. This...
3.
Turkyilmaz A, Devrimsel G, Serdaroglu Beyazal M, Kirbas A, Cicek Y, Capkin E, et al.
Acta Reumatol Port
. 2016 Sep;
42(2):183-190.
PMID: 27680106
Objective: Serum YKL-40 plays roles in inflammatory and vascular processes. Our aim was to evaluate serum YKL-40 levels in patients with ankylosing spondylitis (AS) and to investigate their potential relationship...
4.
Cure M, Cure E, Kalkan Y, Tumkaya L, Aydin I, Kirbas A, et al.
Adv Clin Exp Med
. 2016 Sep;
25(2):219-26.
PMID: 27627553
Background: Adalimumab (ADA) is a potent inhibitor of tumor necrosis factor (TNF-α). ADA treatment suppresses proinflammatory cytokines, leading to a decrease or inhibition of the inflammatory process. Objectives: The aim...
5.
Kirbas S, Kirbas A, Tufekci A, Cumhur Cure M, Cakmak S, Yazici T, et al.
Acta Clin Belg
. 2016 Apr;
71(2):71-5.
PMID: 27075796
Objectives: Endothelial dysfunction has been implicated as a crucial event in the development of several neurodegenerative diseases. The aim of this study was to investigate the serum homocysteine, asymmetric dimethylarginine...
6.
Kir Sahin F, Sahin S, Ural U, Cumhur Cure M, Senturk S, Bayoglu Tekin Y, et al.
Bosn J Basic Med Sci
. 2015 Aug;
15(3):57-63.
PMID: 26295295
Obesity, insulin resistance (IR), inflammation, and hyperandrogenism may lead to polycystic ovary syndrome (PCOS) and hypertension. Nesfatin-1 (N1) may be related to IR, obesity, and hypertension. Furthermore, a vitamin D...
7.
Kirbas A, Cumhur Cure M, Kalkan Y, Cure E, Tumkaya L, Sahin O, et al.
Iran J Kidney Dis
. 2015 May;
9(3):221-9.
PMID: 25957427
Introduction: Methotrexate, an antagonist of folic acid used in the treatment of many cancers and inflammatory diseases, is associated with side effects that limit its usage. Infliximab has been reported...
8.
Cure E, Kirbas A, Tumkaya L, Cumhur Cure M, Kalkan Y, Yilmaz A, et al.
J Cancer Res Ther
. 2015 Apr;
11(1):164-9.
PMID: 25879356
Aims: Although methotrexate (mtx) is a widely used agent to treat cancer and inflammatory diseases, its hepatotoxic effect limits for clinical utility. We aimed to investigate whether infliximab (inf), an...
9.
Sirmali R, Armagan A, Oktem F, Uz E, Kirbas A, Donmezs S, et al.
Turk J Med Sci
. 2015 Mar;
45(1):33-7.
PMID: 25790527
Background/aim: To compare the protective efficacy of erdosteine and vitamins C and E against renal injury caused by hind limb ischemia-reperfusion (I/R). Materials And Methods: Rats were split into 4...
10.
Gumus A, Altintas N, Cinarka H, Kirbas A, Haziroglu M, Karatas M, et al.
Int J Chron Obstruct Pulmon Dis
. 2015 Feb;
10:357-65.
PMID: 25709430
Background: Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory condition, and progresses with acute exacerbations. (AE). During AE, levels of acute phase reactants such as C-reactive protein (CRP) and...